Joakim Crona
Overview
Explore the profile of Joakim Crona including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
1144
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Backman S, Botling J, Nord H, Ghosal S, Stalberg P, Juhlin C, et al.
J Pathol
. 2024 Oct;
264(4):357-370.
PMID: 39360347
Tumour evolution with acquisition of more aggressive disease characteristics is a hallmark of disseminated cancer. Metastatic pancreatic neuroendocrine tumours (PanNETs) in particular may progress from a low/intermediate to a high-grade...
2.
Flynn A, Pattison A, Balachander S, Boehm E, Bowen B, Dwight T, et al.
Res Sq
. 2024 Jul;
PMID: 38978571
Hereditary -mutant pheochromocytomas (PC) and paragangliomas (PG) are rare tumours with a high propensity to metastasize although their clinical behaviour is unpredictable. To characterize the genomic landscape of these tumours...
3.
Falkman L, Sundin A, Skogseid B, Botling J, Bernardo Y, Wallin G, et al.
Ups J Med Sci
. 2024 May;
129.
PMID: 38716076
Background: Metastatic neuroendocrine carcinoma (NEC) is associated with short survival. Other than platinum-based chemotherapy, there is no clear standard regimen. Current guidelines suggest that combination treatment with BRAF-inhibitors should be...
4.
Pang Y, Zhang J, Jiang J, Pamporaki C, Li M, Bechmann N, et al.
Clin Endocrinol (Oxf)
. 2024 Apr;
101(3):234-242.
PMID: 38606576
Objective: Paragangliomas of the urinary bladder (UBPGLs) are rare neuroendocrine tumours and pose a diagnostic and surgical challenge. It remains unclear what factors contribute to a timely presurgical diagnosis. The...
5.
Backman S, Botling J, Nord H, Ghosal S, Stalberg P, Juhlin C, et al.
medRxiv
. 2024 Feb;
PMID: 38313278
Tumour evolution with acquisition of more aggressive disease characteristics is a hallmark of disseminated cancer. Metastatic pancreatic neuroendocrine tumours (PanNETs) in particular, show frequent progression from a low/intermediate to a...
6.
Taieb D, Nolting S, Perrier N, Fassnacht M, Carrasquillo J, Grossman A, et al.
Nat Rev Endocrinol
. 2023 Dec;
20(3):168-184.
PMID: 38097671
Adult and paediatric patients with pathogenic variants in the gene encoding succinate dehydrogenase (SDH) subunit B (SDHB) often have locally aggressive, recurrent or metastatic phaeochromocytomas and paragangliomas (PPGLs). Furthermore, SDHB...
7.
Zhang L, Akerstrom T, Mollazadegan K, Beuschlein F, Pacak K, Skogseid B, et al.
Endocr Relat Cancer
. 2023 Nov;
31(1).
PMID: 38031994
No abstract available.
8.
Kjaer J, Clancy T, Thornell A, Andersson N, Hellman P, Crona J, et al.
Ann Surg Open
. 2023 Aug;
3(1):e151.
PMID: 37600107
Objective: To determine the association of primary tumor resection in stage IV pancreatic neuroendocrine tumors (Pan-NET) and survival in a propensity-score matched study. Background: Pan-NET are often diagnosed with stage...
9.
Zhang L, Akerstrom T, Mollazadegan K, Beuschlein F, Pacak K, Skogseid B, et al.
Endocr Relat Cancer
. 2023 May;
30(7).
PMID: 37185155
Core needle biopsy (CNB) has been used with caution in pheochromocytoma and paraganglioma (PPGL) due to concerns about catecholamine-related complications. While it is unclear what scientific evidence supports this claim,...
10.
Ghosal S, Hadrava Vanova K, Uher O, Das S, Patel M, Meuter L, et al.
Endocrine
. 2022 Nov;
79(1):171-179.
PMID: 36370152
Purpose: To understand prognostic immune cell infiltration signatures in neuroendocrine neoplasms (NENs), particularly pheochromocytoma and paraganglioma (PCPG), we analyzed tumor transcriptomic data from The Cancer Genome Atlas (TCGA) and other...